atorvastatin has been researched along with Cancer of the Uterus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ghafarzadeh, M; Marzban Rad, Z; Shakarami, A; Yari, F | 1 |
Li, S; Shen, Q; Shen, Z; Sheng, B; Sun, LZ; Zhu, H; Zhu, X | 1 |
Cunnane, G; Durcan, L; Gleeson, N; McKiernan, S | 1 |
1 trial(s) available for atorvastatin and Cancer of the Uterus
Article | Year |
---|---|
The role of anti-proliferative effects of atorvastatin on uterine fibroids: findings from a clinical study.
Topics: Adult; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leiomyoma; Placebos; Ultrasonography; Uterine Neoplasms | 2021 |
2 other study(ies) available for atorvastatin and Cancer of the Uterus
Article | Year |
---|---|
The role of atorvastatin in suppressing tumor growth of uterine fibroids.
Topics: Adult; Apoptosis; Atorvastatin; Cell Proliferation; Female; Humans; Hyperlipidemias; Leiomyoma; MAP Kinase Signaling System; Middle Aged; Phenotype; Phosphorylation; Polyisoprenyl Phosphates; Sesquiterpenes; Uterine Neoplasms | 2018 |
A benign tumor as the apparent trigger for myopathy.
Topics: Aged; Atorvastatin; Female; Gynecologic Surgical Procedures; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Leg; Leiomyoma; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Neoplasms; Pyrroles; Treatment Outcome; Uterine Neoplasms | 2014 |